Tag Archive > Today Announced That

EANS-Adhoc: WINCOR NIXDORF Aktiengesellschaft / Amicable termination of the mandate of Stefan Auerbach as member of the Board of Directors of Wincor Nixdorf AG

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– 08.02.2012 Paderborn, February 8, 2012. Wincor Nixdorf AG today announced that the company’s Supervisory Board had reached a mutual agreement with Stefan [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Takeda’s Edarbi® (azilsartan medoxomil) Receives European Marketing Authorisation for the Treatment of Essential Hypertension

London and Osaka, Japan (ots/PRNewswire) – Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted marketing authorisation for Edarbi(R) (azilsartan medoxomil), a new once-daily angiotensin receptor blocker (ARB) (also known as angiotensin II receptor antagonist [AIIRA]) for the treatment of essential hypertension (high blood pressure) in adults.[1] Takeda will launch azilsartan [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

NTT Europe Expands its Global IP Network into Eastern Europe

LONDON, BUDAPEST, BUCHAREST & SOFIA, Bulgaria, November 18, 2011 (ots/PRNewswire) — ? NTT Europe, a wholly owned subsidiary of NTT Communications Corporation [http://www.ntt.com/index-e.html ] (NTT Com), today announced that it has expanded the reach of NTT Communications’ Tier 1 Global IP Network in Europe with new Points of Presence (PoP) locations in Budapest, Bucharest and [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-Adhoc: AGENNIX AG / Agennix AG Announces Planned Rights Offering and Capital Increase

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Rights Offering, Capital Increase 16.11.2011 Planegg/Munich (Germany), November 16, 2011 – Agennix AG (Frankfurt Stock Exchange (Prime Standard): AGX/ISIN DE000A1A6XX4) today [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Sunshine Biopharma Announces Successful Completion of Preclinical Studies for Adva-27a, the Company’s Lead Anti-Cancer Compound

Montreal, November 16 (ots/PRNewswire) – Sunshine Biopharma Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has successfully completed the preclinical studies for Adva-27a, the Company’s lead oncology drug candidate. Adva-27a was found to have unique pharmaceutical [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union

Thousand Oaks, California, November 15 (ots/PRNewswire) – Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix(R) (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: Identive Group Inc. / idOnDemand Integrates Symantec Validation and ID Protection (VIP) Service to Deliver Secure Authentication on Mobile Devices

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products Pleasanton, Calif., November 14, 2011 (euro adhoc) – idOnDemand, the pioneer in smart identification and a business unit of Identive Group, Inc. (NASDAQ: INVE: Frankfurt: INV), today announced that its idOnDemand SmartID card now [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: aleo solar AG / aleo solar AG boosts international revenue in the first nine months of 2011 and reduces revenue forecast

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– 9-month report Prenzlau/Oldenburg (euro adhoc) – aleo solar AG (ISIN: DE000A0JM634) today announced that it generated revenue of EUR 344.6 million in the first nine months of 2011. This means that aleo solar’s revenue decreased by [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-Adhoc: aleo solar AG / aleo solar AG reduces revenue forecast for the full 2011 year

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– 09.11.2011 aleo solar AG (ISIN: DE000A0JM634) today announced that it generated revenue of EUR 344.6 million in the first nine months of [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Agendia Appoints New CEO and Supervisory Board Member

Irvine, California and Amsterdam (ots/PRNewswire) – Agendia, an innovative molecular diagnostics company, today announced that its supervisory board of directors has appointed David Macdonald as chief executive officer. This follows the resignation of the company’s co-founder and chief executive officer, Dr. Bernhard Sixt. Dr. Sixt will remain with the company in an advisory capacity. Agendia [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Agendia Successfully Completes Bi-Annual FDA Inspection

Irvine, California and Amsterdam (ots/PRNewswire) – Agendia, an innovative molecular cancer diagnostics company, today announced that the company successfully completed a recent, routine inspection of its Irvine, California-based laboratories by the US Food and Drug Administration (FDA). Agendia received FDA 510(k) clearance for its MammaPrint(R) breast cancer recurrence test in early 2007. It remains the [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Alex Payne Joins PokerStars as Chief Marketing Officer

Douglas, Isle Of Man (ots/PRNewswire) – – Latest Appointment Rounds Out New Senior Leadership Team Built Over the Last 12 Months PokerStars today announced that Alex Payne has joined the entertainment and technology company as Chief Marketing Officer responsible for all aspects of consumer marketing across the business. Payne will lead all central and regional [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: aleo solar AG / aleo solar AG announces positive earnings for the year´s first half and lowers revenue forecast because of massively falling prices

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– quarterly report Prenzlau/Oldenburg (euro adhoc) – aleo solar AG (ISIN: DE000A0JM634) today announced that it generated revenue of EUR 232.0 million in the first six months of 2011. This means that aleo solar’s revenue decreased by [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EMA Accepts Eisai’s License Extension Application for Zonisamide in Epilepsy

Hatfield, England (ots/PRNewswire) – Eisai today announced that the European Medicines Agency (EMA) has accepted for review their application to extend the use of zonisamide as monotherapy for newly diagnosed epilepsy patients with partial seizures, with and without second generalisation. Zonisamide is a second generation anti-epileptic drug with multiple mechanisms of action, with a chemical [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: asknet AG / Unscheduled provisions have negative impact on H1 results

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information Subtitle: +++ Tax authorities issue notification of interest charge due to a formal error during VAT calculations for software publishers +++ asknet assesses legal options and will apply for suspended payment Karlsruhe (euro adhoc) [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

prev posts